Clinical trial

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

NCT06326086

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Chemotherapy drug Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Targeted Agent Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Immunotherapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2022-08-01

PhaseN/A

Conditions

Advanced Lung Cancerunresolved

Sarcopeniaunresolved

Interventions

Chemotherapy drugDRUG

Targeted AgentDRUG

ImmunotherapyDRUG

Sponsors & collaborators

Prince of Songkla Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06326086 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.